Hall Steven Edward

10% owner at Protagonist Therapeutics, Inc · on record since Aug 16, 2016
Director at Cerulean Pharma Inc. · on record since Apr 15, 2014
10% owner at Cerulean Pharma Inc. · on record since Apr 15, 2014
10% owner at AMERICAN CLAIMS EVALUATION INC · on record since Jun 28, 2017
Former 10% owner at AMERICAN CLAIMS EVALUATION INC · on record since Jul 7, 2017
10% owner at Surface Oncology, Inc. · on record since Apr 23, 2018
Director at Forma Therapeutics Holdings, Inc., · on record since Jun 22, 2020
Director at Kymera Therapeutics, Inc. · on record since Aug 25, 2020

Insider trading activity of Hall Steven Edward

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Price	Value · USD	Src
Kymera Therapeutics, Inc.	Jun 17, 2021	AwardD	20,063	0.00 USD	$0	SEC
Forma Therapeutics Holdings, Inc.,	Nov 25, 2020	Other	2,106,828	—	—	SEC
Forma Therapeutics Holdings, Inc.,	Nov 25, 2020	OtherD	-3,178,630	0.00 USD	$0	SEC
Forma Therapeutics Holdings, Inc.,	Nov 25, 2020	OtherD	-5,833,333	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Aug 25, 2020	Other	2,192,249	—	—	SEC
Kymera Therapeutics, Inc.	Aug 25, 2020	OtherD	-985,220	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Aug 25, 2020	OtherD	-2,511,198	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Aug 21, 2020	AwardD	40,127	0.00 USD	$0	SEC
Forma Therapeutics Holdings, Inc.,	Jun 22, 2020	AwardD	17,533	0.00 USD	$0	SEC
Surface Oncology, Inc.	Apr 23, 2018	OtherD	-7,000,000	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	Buy	266,000	15.00 USD	$4M	SEC
Surface Oncology, Inc.	Apr 23, 2018	Other	3,181,817	—	—	SEC
Cerulean Pharma Inc.	Jun 30, 2015	AwardD	11,000	0.00 USD	$0	SEC
Cerulean Pharma Inc.	Apr 15, 2014	OtherD	-13,513,513	0.00 USD	$0	SEC
Cerulean Pharma Inc.	Apr 15, 2014	OtherD	0	0.00 USD	$0	SEC
Cerulean Pharma Inc.	Apr 15, 2014	Other	192,209	—	—	SEC
Cerulean Pharma Inc.	Apr 15, 2014	OtherD	0	0.00 USD	$0	SEC
Cerulean Pharma Inc.	Apr 15, 2014	Other	199,875	—	—	SEC
Cerulean Pharma Inc.	Apr 15, 2014	Buy	733,445	7.00 USD	$5.1M	SEC
Cerulean Pharma Inc.	Apr 15, 2014	OtherD	-4,340,831	0.00 USD	$0	SEC
Cerulean Pharma Inc.	Apr 15, 2014	Other	299,213	—	—	SEC
Cerulean Pharma Inc.	Apr 15, 2014	Other	931,485	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Kymera Therapeutics, Inc.	Jun 17, 2021	AwardD	20,063	0.00 USD	$0	SEC
Forma Therapeutics Holdings, Inc.,	Nov 25, 2020	Other	2,106,828	—	—	SEC
Forma Therapeutics Holdings, Inc.,	Nov 25, 2020	OtherD	-3,178,630	0.00 USD	$0	SEC
Forma Therapeutics Holdings, Inc.,	Nov 25, 2020	OtherD	-5,833,333	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Aug 25, 2020	Other	2,192,249	—	—	SEC
Kymera Therapeutics, Inc.	Aug 25, 2020	OtherD	-985,220	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Aug 25, 2020	OtherD	-2,511,198	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Aug 21, 2020	AwardD	40,127	0.00 USD	$0	SEC
Forma Therapeutics Holdings, Inc.,	Jun 22, 2020	AwardD	17,533	0.00 USD	$0	SEC
Surface Oncology, Inc.	Apr 23, 2018	OtherD	-7,000,000	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	Buy	266,000	15.00 USD	$4M	SEC
Surface Oncology, Inc.	Apr 23, 2018	Other	3,181,817	—	—	SEC
Cerulean Pharma Inc.	Jun 30, 2015	AwardD	11,000	0.00 USD	$0	SEC
Cerulean Pharma Inc.	Apr 15, 2014	OtherD	-13,513,513	0.00 USD	$0	SEC
Cerulean Pharma Inc.	Apr 15, 2014	OtherD	0	0.00 USD	$0	SEC
Cerulean Pharma Inc.	Apr 15, 2014	Other	192,209	—	—	SEC
Cerulean Pharma Inc.	Apr 15, 2014	OtherD	0	0.00 USD	$0	SEC
Cerulean Pharma Inc.	Apr 15, 2014	Other	199,875	—	—	SEC
Cerulean Pharma Inc.	Apr 15, 2014	Buy	733,445	7.00 USD	$5.1M	SEC
Cerulean Pharma Inc.	Apr 15, 2014	OtherD	-4,340,831	0.00 USD	$0	SEC
Cerulean Pharma Inc.	Apr 15, 2014	Other	299,213	—	—	SEC
Cerulean Pharma Inc.	Apr 15, 2014	Other	931,485	—	—	SEC